NDC 0002-2377-11
EMGALITY 120 mg/mL
galcanezumab-gnlm · INJECTION, SOLUTION
EMGALITY is a injection, solution containing galcanezumab-gnlm at a strength of 120 mg/mL. Manufactured by Eli Lilly and Company.
Key Facts
- Brand Name
- EMGALITY
- Generic Name
- galcanezumab-gnlm
- NDC Code (Package)
0002-2377-11- NDC Code (Product)
0002-2377- Manufacturer
- Eli Lilly and Company
- Strength
- 120 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761063
- Marketing Start
- 09/27/2018
Recall History
No Recall HistoryView Full Drug Page
EMGALITY — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.